Past Residents

Alexis Bogannam, PharmD (2022 - 2023)

• Residency Project: Impact of American Diabetes Association 2022 Guidelines on Prescribing Rates of Sodium-Glucose Cotransporter-2 Inhibitors in Ambulatory Care Organization Patients With Type 2 Diabetes
• Position obtained after completion of PGY1: Clinical Pharmacy Specialist, Beth Israel Lahey Health

Kelli Sims, PharmD (2020-2021)

• Residency project: Management of generic valsartan recall at a multi-site, ambulatory care organization
• Position obtained after completion of PGY1: Community Care Clinical Pharmacist, University Health, TX

Thu-Trang Nguyen, PharmD (2019-2020)

• Residency project: Optimization of medication point-of-prescribing alerts at a multi-site, ambulatory care organization to aid clinical care and reduce health care cost
• Position obtained after completion of PGY1: Clinical Pharmacist, Lifespan, RI

Stefanos Torkos, PharmD (2018-2019)

• Residency project: Evaluation of patient factors associated with achieving goal hemoglobin A1c in collaborative drug therapy management ambulatory care clinics by clinical pharmacists: a retrospective chart review
• Position obtained after completion of PGY1: Transitions of Care Clinical Pharmacist, BayCare Health System, FL

Patrick McCarthy, PharmD (2017-2018)

• Residency project: Clinical response and cost-savings associated with generic fluticasone propionate/salmeterol multidose, dry-powder inhaler in asthma patients managed in an ambulatory care practice setting
• Position obtained after completion of PGY1: Clinical Pharmacy Specialist, Lahey Health, MA

Semie Durrani, PharmD (2016-2017)

• Residency project: Opioid prescribing: a retrospective analysis of opioid prescription requests in a large, multicenter ambulatory care organization
• Position obtained after completion of PGY1: Population Health Clinical Pharmacist, Hunterdon Healthcare, NY

Timothy Bach, PharmD (2015-2016)

• Residency project: Treating hepatitis C virus genotypes 1-4 in a large multisite ambulatory care practice setting: outcomes with direct-acting antiviral regimens
• Position obtained after completion of PGY1: Transitions of Care Clinical Pharmacist, BayCare Health System, FL

Sandra Elman, PharmD (2014-2015)

• Residency project: Evidence-based beta-blocker use in systolic heart failure: clinical pharmacy impact on achieving a medicare pioneer ACO quality measure in an ambulatory care setting
• Position obtained after completion of PGY1: Clinical Pharmacist, Informatics, Atrius Health, MA 

Emily Zouzas (Barker), PharmD (2013-2014)

• Residency project: Implementation of a clinical pharmacist-run medication reconciliation telephone service for new patients entering a primary care practice
• Position obtained after completion of PGY1: Clinical Pharmacy Specialist, Cambridge Health Alliance, MA

Ricky Thumar, PharmD (2012-2013)

• Residency project: Analysis of clinical pharmacist impact on low density lipoprotein cholesterol values in patients with cardiovascular disease through a live, primary care-based intervention program
• Position obtained after completion of PGY1: Assistant Professor of Pharmacy Practice, MCPHS University; Clinical Pharmacist, Codman Square Health Center, MA

Andrew Bundeff, PharmD (2011-2012)

• Residency project: Impact of clinical pharmacists’ recommendations on a proton pump inhibitor taper protocol in an ambulatory care practice
• Position obtained after completion of PGY1: PGY1 Residency Program Director, Wake Forest Baptist Health, NC